Back to search

Article

Aptamer-Protamine-siRNA Nanoparticles in Targeted Therapy of ErbB3 Positive Breast Cancer Cells

2020-07-17

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>RNAi-based technology has achieved good results in both <italic>in vitro</italic> and <italic>in vivo </italic>applications, and it is expected to become a good genetic treatment for some diseases, especially neoplastic diseases. But there are still many obstacles in the <italic>in vivo</italic> application, the most important thing is the lack of an efficient a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
66e54aae-1402-5b17-bcec-86ad3a66e8c0
DOI
10.21203/rs.3.rs-42522/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aptamer-Protamine-siRNA Nanoparticles in Targeted Therapy of ErbB3 Positive Breast Cancer CellsDOI 10.21203/rs.3.rs-42522/v1
Select a neighboring publication to make it the new centre.